FORT LAUDERDALE, Fla., Nov. 18, 2004 (PRIMEZONE) -- Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), an industry leader in the distribution and manufacturing of Chinese herbs, veterinary medicines and low-calorie natural sweetener in China, announced today its sales of Chinese Herbal for sexual enhancement, which is called Epimedium or Horny Goat Weed, has increased 25% in the first six months of 2004 to 12.5 tons as compared to the same period in 2003. Epimedium is a Chinese herb which is a major component of natural sexual enhancement supplements. The company expects to produce 30 tons in 2004 and to increase to 50 tons in 2005.
Baozhong Yuan, CEO of Sunwin International, commented, "In 2003, our production of Epimedium ("Horny Goat Weed") represented approximately 4.5% of the global market share. Our goal is to increase our market share to 6.75% in 2004 and 11% in 2005 worldwide, respectively. As animal studies have shown the effectiveness and safety of Epimedium, we believe the applications of Epimedium will gain widespread acceptance."
Epimedium is a genus of twenty-one related plant species. The Chinese refer to Epimedium as "yin yang huo", which has been loosely translated as "licentious goat plant" and explains why Western supplement companies have adopted the titillating name by which it is known in the U.S as horny goat weed. The traditional use of Epimedium has been to treat fatigue and boost sex drive, in turn the majority of the claims for Western dietary supplements center around sex drive. The use of Epimedium as a medicinal herb dates back to at least 400 A.D., where it has been used as a tonic for the reproductive system (boosting libido and treating impotence) and as a rejuvenating tonic (to relieve fatigue). Epimedium is thought to work via modulation of Cortisol levels (the primary stress hormone). Under conditions of high stress, the increased Cortisol levels are known to cause fatigue and depress sex drive -- so bringing Cortisol levels back into normal ranges is also thought to help restore normal metabolism, energy levels and libido.
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. ("Sunwin") is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, nutraceutical products, natural sweetener (beet sugar), and animal medicine prepared from 100% organic herbal ingredients. Sunwin International Neutraceuticals, Inc. is doing business in China through its subsidiary, Shandong Qufu Natural Green Engineering Company, Limited ("Qufu"). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more information about Sunwin, please visit http://www.sunwin.biz.
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.